Fagan Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-18,517
Closed -$1.2M 105
2020
Q2
$1.2M Buy
18,517
+2,787
+18% +$176K 0.38% 57
2020
Q1
$933K Buy
15,730
+1,250
+9% +$83.4K 0.37% 59
2019
Q4
$1.08M Buy
14,480
+35
+0.2% +$2.46K 0.35% 66
2019
Q3
$911K Hold
14,445
0.35% 65
2019
Q2
$787K Sell
14,445
-286
-2% -$15.4K 0.32% 69
2019
Q1
$794K Buy
14,731
+361
+3% +$22.3K 0.34% 70
2018
Q4
$942K Buy
14,370
+5
+0% +$373 0.48% 54
2018
Q3
$1.13M Buy
14,365
+835
+6% +$59.7K 0.47% 57
2018
Q2
$871K Buy
+13,530
New +$892K 0.39% 61
2016
Q4
Sell
-12,511
Closed -$1.11M 100
2016
Q3
$1.11M Buy
12,511
+265
+2% +$25K 0.68% 43
2016
Q2
$1.17M Buy
12,246
+15
+0.1% +$1.5K 0.75% 41
2016
Q1
$1.27M Buy
12,231
+3,030
+33% +$295K 0.84% 40
2015
Q4
$900K Buy
9,201
+3,731
+68% +$365K 0.6% 46
2015
Q3
$528K Buy
5,470
+1,310
+31% +$138K 0.39% 63
2015
Q2
$436K Buy
4,160
+1,905
+84% +$195K 0.29% 71
2015
Q1
$233K Buy
+2,255
New +$228K 0.17% 87

Other funds holding CVS

Fagan Associates's CVS Position: Q3 2020 in Review

Fagan Associates sold out of CVS Health (CVS) in Q3 2020, closing a stake of 18,517 shares — an estimated $1.2M sold.

Fagan Associates first reported a position in CVS in Q1 2015 and held it in 16 quarters. The position peaked at $1.27M in Q1 2016. 1,815 funds tracked by Wall St. Rank hold CVS as of Q3 2020.

  • Fagan Associates reported no remaining CVS Health position as of Q3 2020 after selling out during the quarter.
  • Fagan Associates sold 18,517 CVS Health shares in Q3 2020, an estimated $1.2M.
  • Fagan Associates first reported a position in CVS Health in Q1 2015 and held it in 16 quarters.
  • Fagan Associates's CVS Health position peaked at $1.27M in Q1 2016.
  • 1,815 funds tracked by Wall St. Rank held CVS Health as of Q3 2020.

Based on Fagan Associates's 13F filing for Q3 2020, filed 2 Nov 2020.